Leone, A.; Muscarella, L.A.; Graziano, P.; Tornese, A.; Grillo, L.R.; Di Lorenzo, A.; Bronzini, M.; Scarpino, S.; Sparaneo, A.; Rossi, G.
Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation. Cancers 2023, 15, 292.
https://doi.org/10.3390/cancers15010292
AMA Style
Leone A, Muscarella LA, Graziano P, Tornese A, Grillo LR, Di Lorenzo A, Bronzini M, Scarpino S, Sparaneo A, Rossi G.
Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation. Cancers. 2023; 15(1):292.
https://doi.org/10.3390/cancers15010292
Chicago/Turabian Style
Leone, Alvaro, Lucia Anna Muscarella, Paolo Graziano, Andrea Tornese, Lucia Rosalba Grillo, Angela Di Lorenzo, Monica Bronzini, Stefania Scarpino, Angelo Sparaneo, and Giulio Rossi.
2023. "Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation" Cancers 15, no. 1: 292.
https://doi.org/10.3390/cancers15010292
APA Style
Leone, A., Muscarella, L. A., Graziano, P., Tornese, A., Grillo, L. R., Di Lorenzo, A., Bronzini, M., Scarpino, S., Sparaneo, A., & Rossi, G.
(2023). Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation. Cancers, 15(1), 292.
https://doi.org/10.3390/cancers15010292
